Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA DIVIS LABORATORIES DISHMAN PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 30.0 29.9 100.1% View Chart
P/BV x 3.3 7.6 43.8% View Chart
Dividend Yield % 0.7 0.9 74.7%  

Financials

 DISHMAN PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
DIVIS LABORATORIES
Mar-22
DISHMAN PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3745,425 6.9%   
Low Rs1293,562 3.6%   
Sales per share (Unadj.) Rs197.0337.5 58.4%  
Earnings per share (Unadj.) Rs21.2111.5 19.0%  
Cash flow per share (Unadj.) Rs34.7123.3 28.2%  
Dividends per share (Unadj.) Rs2.0030.00 6.7%  
Avg Dividend yield %0.80.7 119.0%  
Book value per share (Unadj.) Rs179.9441.8 40.7%  
Shares outstanding (eoy) m80.70265.47 30.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.313.3 9.6%   
Avg P/E ratio x11.940.3 29.5%  
P/CF ratio (eoy) x7.336.5 19.9%  
Price / Book Value ratio x1.410.2 13.8%  
Dividend payout %9.426.9 35.1%   
Avg Mkt Cap Rs m20,3071,192,890 1.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3559,462 56.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89889,598 17.7%  
Other income Rs m2651,159 22.9%   
Total revenues Rs m16,16390,757 17.8%   
Gross profit Rs m4,10338,811 10.6%  
Depreciation Rs m1,0913,115 35.0%   
Interest Rs m94420 4,722.0%   
Profit before tax Rs m2,33436,835 6.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6247,231 8.6%   
Profit after tax Rs m1,71029,605 5.8%  
Gross profit margin %25.843.3 59.6%  
Effective tax rate %26.719.6 136.1%   
Net profit margin %10.833.0 32.6%  
BALANCE SHEET DATA
Current assets Rs m11,01896,104 11.5%   
Current liabilities Rs m9,51724,544 38.8%   
Net working cap to sales %9.479.9 11.8%  
Current ratio x1.23.9 29.6%  
Inventory Days Days579 654.7%  
Debtors Days Days3987 0.4%  
Net fixed assets Rs m18,78750,087 37.5%   
Share capital Rs m161531 30.4%   
"Free" reserves Rs m14,354116,751 12.3%   
Net worth Rs m14,516117,282 12.4%   
Long term debt Rs m4,1890-   
Total assets Rs m29,805146,191 20.4%  
Interest coverage x3.51,842.8 0.2%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.6 87.0%   
Return on assets %8.920.3 43.9%  
Return on equity %11.825.2 46.7%  
Return on capital %17.531.4 55.8%  
Exports to sales %24.90-   
Imports to sales %3.719.7 18.9%   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m59417,676 3.4%   
Fx inflow Rs m4,95278,445 6.3%   
Fx outflow Rs m69717,953 3.9%   
Net fx Rs m4,25560,492 7.0%   
CASH FLOW
From Operations Rs m2,78619,118 14.6%  
From Investments Rs m-1,529-21,949 7.0%  
From Financial Activity Rs m-941-5,324 17.7%  
Net Cashflow Rs m317-8,156 -3.9%  

Share Holding

Indian Promoters % 61.4 51.9 118.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 36.2 63.4%  
FIIs % 12.0 15.4 77.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 48.1 80.3%  
Shareholders   52,291 379,257 13.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Divis Laboratories Share Price Performance

Period Dishman Pharma Divis Laboratories S&P BSE HEALTHCARE
1-Day 2.87% 1.01% 0.23%
1-Month -2.45% -4.84% 0.36%
1-Year 96.38% -31.54% -6.87%
3-Year CAGR 50.28% 23.48% 20.16%
5-Year CAGR 41.17% 26.72% 11.07%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 26.9%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 211 Points | Tyre Stocks Rally while Metals Drag | 4 Reasons Why Indian Share Markets Hit Record High(Closing)

After opening the day lower mirroring weakness in Asian peers, Indian share markets staged a comeback and ended the trading session on an optimistic note.